SCHEMBL6405719

SCHEMBL6405719

O=c1[nH]c2c(O)cccc2c2c1CCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
HSD17B10 Q99714 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
TSHR P16473 1/20 0.44
GFER P55789 1/20 0.44
EGFR P00533 1/20 0.44
PRKCA P17252 1/20 0.44
PARP1 P09874 2/20 0.44
ALOX15 P16050 2/20 0.43
MAPK1 P28482 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PLA2G7 Q13093 5/20 0.42
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
MAPT P10636 1/20 0.40
ROCK2 O75116 1/20 0.39
PARP14 Q460N5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2315927 0.78 KDM4E (0.68) KDM4EHSD17B10ALDH1A1HPGDGFER
SCHEMBL6642367 0.77 HSD17B10 (0.44) KDM4EHSD17B10GFERPARP1ALOX15
SCHEMBL6402848 0.76 HPGD (0.57) KDM4EALDH1A1HPGDTSHRPARP1
SCHEMBL12764968 0.74 GFER (0.49) KDM4EHSD17B10ALDH1A1HPGDGFER
SCHEMBL12764985 0.72 CLEC4M (0.53) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL12764963 0.72 GFER (0.47) KDM4EHSD17B10ALDH1A1HPGDGFER
SCHEMBL30158836 0.72 HSD17B10 (0.61) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL29271635 0.71 HSD17B10 (0.34) KDM4EHSD17B10ALDH1A1GFERPARP1
SCHEMBL5332369 0.69 EGFR (0.50) KDM4EHSD17B10ALDH1A1HPGDEGFR
SCHEMBL11814599 0.69 AR (0.57) KDM4EHSD17B10ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171101-A1 Phenanthridinones as parp inhibitors FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-08-04 US disclosed
EP-1487800-A1 PHENANTHRIDINONES AS PARP INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed
WO-2003080581-A1 PHENANTHRIDINONES AS PARP INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171101-A1 Phenanthridinones as parp inhibitors PARP1, PARP11, PARP2 KDM4E 721/4885HSD17B10 1633/4885ALDH1A1 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.